| Zdroj: |
Juul, K V, Thomsen, V O, Nissen, A, Hallas, J, Kolmos, H J, Funch-Jensen, P M & Lauritsen, K 1999, ' National overvågning af Helicobacter pylori-eradikationsterapi i Danmark : Resultater fra registreringen af 34.582 receptudskrivninger ', Ugeskrift for læger, bind 161, nr. 48, s. 6635-8 . |
| Popis: |
We wanted to characterize the use of H. pylori eradication therapy in Denmark (inhabitants 5,227,862). All H. pylori eradication treatments from a nation wide database covering all drug prescriptions in the period January 1994-June 1996 were identified. We found 28,784 out-patients having a prescription with drugs for H. pylori eradication, accounting for 34,582 prescriptions in total. The incidence of new consumers was 220 per 10(5) inhabitants per year, with a maximum at 70-79 years of age. Eighty-six percent of the patients had only one treatment course. Forty-five percent had an anti-ulcer drug prescribed 1-12 months after the H. pylori eradication therapy. Consumption of antibiotics used for H. pylori eradication accounted for 1.4% of the total consumption of antibiotics. In conclusion, the incidence of H. pylori eradication therapy was fairly stable but with changes in the pattern of drug regimens used. Anti-ulcer drugs were often given after H. pylori eradication therapy, suggesting an inappropriate use of eradication treatment. |
